To test whether Notch inhibition through GSI XII affects myeloma bone disease, we used a recently described murine MOPC315.BM model,22 which recapitulates the main characteristics of human MM with particular respect to myeloma-specific monoclonal IgA serum levels and abundant osteolytic lesions. This evidence concerns the gene CD79A and plasma cell myeloma.